SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001663577-17-000228
Filing Date
2017-07-17
Accepted
2017-07-17 14:16:49
Documents
40
Period of Report
2017-05-31

Document Format Files

Seq Description Document Type Size
1 mainbody.htm 10-Q 307801
2 GRAPHIC image_002.jpg GRAPHIC 5075
3 ex31_1.htm EX-31.1 9016
4 ex31_2.htm EX-31.2 9004
5 ex32_1.htm EX-32.1 3978
  Complete submission text file 0001663577-17-000228.txt   1101846

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bkit-20170531.xml EX-101.INS 102034
7 XBRL SCHEMA FILE bkit-20170531.xsd EX-101.SCH 16255
8 XBRL CALCULATION FILE bkit-20170531_cal.xml EX-101.CAL 21606
9 XBRL DEFINITION FILE bkit-20170531_def.xml EX-101.DEF 17816
10 XBRL LABEL FILE bkit-20170531_lab.xml EX-101.LAB 86856
11 XBRL PRESENTATION FILE bkit-20170531_pre.xml EX-101.PRE 69080
Mailing Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001
Business Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001 (646) 453-4912
Blake Insomnia Therapeutics, Inc. (Filer) CIK: 0001556416 (see all company filings)

IRS No.: 460780380 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-55022 | Film No.: 17967327
SIC: 7200 Services-Personal Services